Cargando…
Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
The investigational drugs E7820, indisulam and tasisulam (aryl-sulfonamides) promote the degradation of the splicing factor RBM39 in a proteasome-dependent mechanism. While the activity critically depends on the Cullin RING ligase substrate receptor DCAF15, the molecular details remain elusive. Here...
Autores principales: | Faust, Tyler, Yoon, Hojong, Nowak, Radosław P., Donovan, Katherine A., Li, Zhengnian, Cai, Quan, Eleuteri, Nicholas A., Zhang, Tinghu, Gray, Nathanael S., Fischer, Eric S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6917914/ https://www.ncbi.nlm.nih.gov/pubmed/31686031 http://dx.doi.org/10.1038/s41589-019-0378-3 |
Ejemplares similares
-
E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial
por: Bewersdorf, Jan Philipp, et al.
Publicado: (2023) -
Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells
por: Chen, Wei-Ching, et al.
Publicado: (2021) -
Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations
por: de Wispelaere, Mélissanne, et al.
Publicado: (2019) -
Template-assisted covalent modification of DCAF16 underlies activity of BRD4 molecular glue degraders
por: Li, Yen-Der, et al.
Publicado: (2023) -
Exploration of the Tunability of BRD4 Degradation by DCAF16 Trans-labelling Covalent Glues
por: Hassan, Muhammad Murtaza, et al.
Publicado: (2023)